estronorm 1mg
meda pharma gmbh & co. kg (8043598) - estradiol-hemihydrat - filmtablette - teil 1 - filmtablette; estradiol-hemihydrat (27668) 1,033 milligramm
estronorm 2mg
meda pharma gmbh & co. kg (8043598) - estradiol-hemihydrat - filmtablette - teil 1 - filmtablette; estradiol-hemihydrat (27668) 2,066 milligramm
denstron 1 mg filmtabletten
medis ehf (8020433) - granisetronhydrochlorid - filmtablette - teil 1 - filmtablette; granisetronhydrochlorid (24571) 1,12 milligramm
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastische mittel - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
imbruvica
janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.
conjugen dragees
fujisawa deutschland gmbh - equilin-3-hydrogensulfat-natriumsalz, natrium(estron-3-sulfat) - dragees - equilin-3-hydrogensulfat-natriumsalz 0.2mg; natrium(estron-3-sulfat) 0.8mg
gt 50 b
gewo gmbh (3077581) - ergocalciferol; neostigminbromid; estron; procainhydrochlorid; progesteron; carbachol - injektionslösung - teil 1 - injektionslösung; ergocalciferol (00057) 12,5 milligramm; neostigminbromid (00112) 0,25 milligramm; estron (00234) 1 milligramm; procainhydrochlorid (00271) 10 milligramm; progesteron (00273) 5 milligramm; carbachol (00582) 0,08 milligramm
gyno-hormetten
nycomed arzneimittel gmbh (3039994) - estriol; natrium(estron-3-sulfat); natriumprasteronsulfat - magensaftresistente überzogene tablette - teil 1 - magensaftresistente überzogene tablette; estriol (01888) 0,1 milligramm; natrium(estron-3-sulfat) (03175) 0,25 milligramm; natriumprasteronsulfat (11538) 20 milligramm
oestro-sigletten
röhm gmbh & co.kg (3082814) - equilin-3-hydrogensulfat-natriumsalz; natrium(estron-3-sulfat); 17alpha-hydroxyestra-1,3,5(10),7-tetraen-3-ylhydrogensulfat-natriumsalz - lacktabletten - equilin-3-hydrogensulfat-natriumsalz (3174) 437,5 mikrogramm; natrium(estron-3-sulfat) (3175) 812,5 mikrogramm; 17alpha-hydroxyestra-1,3,5(10),7-tetraen-3-ylhydrogensulfat-natriumsalz (3176) 187,5 mikrogramm
oestroverin
merck kommanditgesellschaft auf aktien (3002287) - natrium(estron-3-sulfat); natrium(estradiol-3-sulfat) - dragees - natrium(estron-3-sulfat) (3175) 620 mikrogramm; natrium(estradiol-3-sulfat) (5002) 380 mikrogramm